Biohaven Pharma (BHVN) Tops Q1 EPS by 41c

Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.98), $0.41 better than the analyst estimate of ($1.39).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
• CrowdStrike posts record ARR growth, raises full-year outlook